After years of trying to expand its online presence through organic growth, giant drug store chain Walgreen has decided to buy a bigger Web footprint, acquiring drugstore.com, the country’s eighth-largest e-tailer — and it’s p…
CVS Caremark has agreed to pay $77.6 million in fines for illegally selling a chemical, common in some cold and cough medicines, that ended up being used to make methamphetamine.
Continue reading CVS to Pay $77…
Drugstore chain Walgreen Co. (WAG) posted earnings of 49 cents per diluted share for the quarter, compared with 44 cents per share a year ago.
Sales for the quarter rose 7.4% to $16.9 billion in the quarter ended Aug. 31, the company said in a statem…
Novartis (NVS) agreed to sell the U.S. rights to bladder medicine Enablex for $400 million.
Ireland-based Warner Chilcott will take over the marketing, sales and manufacturing of the drug in the United States, Novartis said in a statement. The deal is expected to close by the end of October.
Novartis may also receive “milestone payments” of as much as $20 million.
In 2005, Novartis…
Continue reading Novartis Sells U.S. Rights to Enablex for $400 Million
Novartis Sells U.S. Rights to Enablex for $400 Million originally appeared on DailyFinance on Fri, 24 Sep 2010 06:46:00.
Filed Under: Company News, Health Care, Novartis, Insurance, Retail
Rite Aid Corporation (RAD) announced a quarterly loss of 23 cents per diluted share, compared to a loss of 14 cents per share a year earlier, thanks to refinancing costs and falling revenues.
Revenue for the quarter ending Aug. 28 was $6.2 billion, compared with $6.3 billion a year earlier, the company said in a statement. Same store sales fell 1.5%.
The net loss included a charge…
Continue reading Rite Aid Earnings Highlight Another Rough Quarter
Rite Aid Earnings Highlight Another Rough Quarter originally appeared on DailyFinance on Thu, 23 Sep 2010 08:16:00.
Filed Under: Company News, Economy, Health Care, Retail